Literature DB >> 1975506

Demonstration of immunoreactive vasoactive intestinal peptide (IR-VIP) and somatostatin (IR-SOM) in rat thymus.

R P Gomariz1, M J Lorenzo, L Cacicedo, A Vicente, A G Zapata.   

Abstract

In the present work we demonstrate immunohistochemically the presence of both immunoreactive vasoactive intestinal peptide (IR-VIP) and immunoreactive somatostatin (IR-SOM) cells in the thymus of neonatal and adult rats. IR-VIP and IR-SOM from thymic tissue extracts were identified by gel chromatography, HPLC as VIP standard, and somatostatin S-28, respectively. IR-VIP (352.7 pg/thymus) amounts greater than those of IR-SOM (38.7 pg/thymus) detected by radioimmunoassay in the thymus of 3-month-old rats reflected the abundance of IR-VIP positive cells demonstrated by immunohistochemistry. Somatostatin-like immunoreactive cells were identified as epithelial or neuroendocrine-like cells arranged in the thymic cortico-medullary border, whereas IR-VIP positive cells appeared to be large lymphoid cells distributed along the connective tissue trabeculae. Furthermore, IR-VIP lymphoid cells occurred in the periarteriolar lymphoid tissue of the splenic white pulp where lymphoblasts accumulate. The results are discussed with respect to the mutual interactions between the neuroendocrine and immune systems and the possible role played by neuropeptides in these interactions.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1975506     DOI: 10.1016/0889-1591(90)90017-k

Source DB:  PubMed          Journal:  Brain Behav Immun        ISSN: 0889-1591            Impact factor:   7.217


  9 in total

Review 1.  Functional anatomy of the thymic microenvironment.

Authors:  M D Kendall
Journal:  J Anat       Date:  1991-08       Impact factor: 2.610

2.  A light and electron microscopic quantitative analysis of the innervation of axillary lymph nodes in juvenile and old rats.

Authors:  G E Novotny; A Schöttelndreier; T Heuer
Journal:  J Anat       Date:  1993-08       Impact factor: 2.610

3.  Anti-inflammatory role in septic shock of pituitary adenylate cyclase-activating polypeptide receptor.

Authors:  Carmen Martinez; Catalina Abad; Mario Delgado; Alicia Arranz; Maria G Juarranz; Nieves Rodriguez-Henche; Philippe Brabet; Javier Leceta; Rosa P Gomariz
Journal:  Proc Natl Acad Sci U S A       Date:  2002-01-15       Impact factor: 11.205

4.  Studies on rat and human thymus to demonstrate immunoreactivity of calcitonin gene-related peptide, tyrosine hydroxylase and neuropeptide Y.

Authors:  A Kranz; M D Kendall; B von Gaudecker
Journal:  J Anat       Date:  1997-10       Impact factor: 2.610

5.  Cyclic AMP response element-binding protein and the catalytic subunit of protein kinase A are present in F9 embryonal carcinoma cells but are unable to activate the somatostatin promoter.

Authors:  N Masson; M Ellis; S Goodbourn; K A Lee
Journal:  Mol Cell Biol       Date:  1992-03       Impact factor: 4.272

Review 6.  Innate and adaptive immunity for the pathobiology of Parkinson's disease.

Authors:  David K Stone; Ashley D Reynolds; R Lee Mosley; Howard E Gendelman
Journal:  Antioxid Redox Signal       Date:  2009-09       Impact factor: 8.401

7.  Protective effect of vasoactive intestinal peptide on bone destruction in the collagen-induced arthritis model of rheumatoid arthritis.

Authors:  Yasmina Juarranz; Catalina Abad; Carmen Martinez; Alicia Arranz; Irene Gutierrez-Cañas; Florencia Rosignoli; Rosa P Gomariz; Javier Leceta
Journal:  Arthritis Res Ther       Date:  2005-06-23       Impact factor: 5.156

8.  The effects of vasoactive intestinal peptide on RANKL-induced osteoclast formation.

Authors:  Hongyi Qu; Yan Zhuang; Lin Zhu; Zuohui Zhao; Kelai Wang
Journal:  Ann Transl Med       Date:  2021-01

Review 9.  A Clinical Approach for the Use of VIP Axis in Inflammatory and Autoimmune Diseases.

Authors:  Carmen Martínez; Yasmina Juarranz; Irene Gutiérrez-Cañas; Mar Carrión; Selene Pérez-García; Raúl Villanueva-Romero; David Castro; Amalia Lamana; Mario Mellado; Isidoro González-Álvaro; Rosa P Gomariz
Journal:  Int J Mol Sci       Date:  2019-12-20       Impact factor: 5.923

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.